| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine Sciences Research Group, Department of Medicine, University of Manchester, Manchester [D. W. R., J. R. E. D., A. W.], and Department of Chemical Endocrinology, St. Burtholomew's Hospital, London EC1A 7BE [A. J. L. C.], United Kingdom
Human small cell lung carcinomas (SCLCs) frequently express the adrenocorticotrophin precursor gene proopiomelanocortin. Glucocorticoids usually fail to inhibit this ectopic adrenocorticotrophin production, in contrast to their effects in the pituitary. We have shown three human SCLC cell lines to be globally resistant to glucocorticoid action; in two of these lines this occurs despite the presence of glucocorticoid receptors (GR+). Accordingly, we have cloned and sequenced the GR coding region from one of these two GR+, SCLC cell lines, COR L24, and identified compound heterozygous mutations. One allele had a single nucleotide substitution of A to G in the NH2-terminal domain, which altered Asp to Ser at amino acid 363. The other allele contained a trinucleotide insertion at the 5' boundary of exon 4, which introduced an additional amino acid, Arg453, between the two zinc fingers of the DNA binding domain. In contransfection studies using the glucocorticoid responsive mouse mammary tumor virus-luciferase Ser363 did not alter receptor function. In contrast, Arg453 encoded a GR with 48% Vmax activity compared to wild-type receptor (P < 0.001), with an unchanged EC50. Thus, GR mutations may contribute to the glucocorticoid-resistant phenotype of GR+ COR L24 cells, which could confer survival advantage to this highly malignant neuroendocrine tumor.
1 To whom requests for reprints should be addressed, at Division of Endocrinology and Metabolism, Room B-131, Cedars-Sinai Medical Center, 8700, Beverly Boulevard, Los Angeles, CA 90048-1865. Phone: (310) 855-7667; Fax: (310) 652-7987.
Received 1/10/96. Accepted 5/13/96.
This article has been cited by other articles:
|
|
 |
|
  L. Rice, C. E Waters, J. Eccles, H. Garside, P. Sommer, P. Kay, F. H Blackhall, L. Zeef, B. Telfer, I. Stratford, et al. Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor J. Endocrinol., September 1, 2008; 198(3): 499 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hiller, S. Nikolajewa, K. Huse, K. Szafranski, P. Rosenstiel, S. Schuster, R. Backofen, and M. Platzer TassDB: a database of alternative tandem splice sites Nucleic Acids Res., January 12, 2007; 35(suppl_1): D188 - D192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H Stolte, B M L. V. van Kemenade, H. F J Savelkoul, and G. Flik Evolution of glucocorticoid receptors with different glucocorticoid sensitivity. J. Endocrinol., July 1, 2006; 190(1): 17 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S-I Okazaki, M Yamakawa, K Maeda, N Ohta, and M Aoyagi Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas J. Clin. Pathol., April 1, 2006; 59(4): 410 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Russcher, P. Smit, E. L. T. van den Akker, E. F. C. van Rossum, A. O. Brinkmann, F. H. de Jong, S. W. J. Lamberts, and J. W. Koper Two Polymorphisms in the Glucocorticoid Receptor Gene Directly Affect Glucocorticoid-Regulated Gene Expression J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5804 - 5810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C E Waters, A Stevens, A White, and D W Ray Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line J. Endocrinol., November 1, 2004; 183(2): 375 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Whitaker, S. Hanrahan, N. Totty, S. C. Gamble, J. Waxman, A. C. B. Cato, H. C. Hurst, and C. L. Bevan Androgen Receptor Is Targeted to Distinct Subcellular Compartments in Response to Different Therapeutic Antiandrogens Clin. Cancer Res., November 1, 2004; 10(21): 7392 - 7401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stevens, D. W. Ray, E. Zeggini, S. John, H. L. Richards, C. E. M. Griffiths, and R. Donn Glucocorticoid Sensitivity Is Determined by a Specific Glucocorticoid Receptor Haplotype J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 892 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kunz, R. Sandoval, P. Carlsson, J. Carlstedt-Duke, J. W. Bloom, and R. L. Miesfeld Identification of a Novel Glucocorticoid Receptor Mutation in Budesonide-Resistant Human Bronchial Epithelial Cells Mol. Endocrinol., December 1, 2003; 17(12): 2566 - 2582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stevens, H. Garside, A. Berry, C. Waters, A. White, and D. Ray Dissociation of Steroid Receptor Coactivator 1 and Nuclear Receptor Corepressor Recruitment to the Human Glucocorticoid Receptor by Modification of the Ligand-Receptor Interface: The Role of Tyrosine 735 Mol. Endocrinol., May 1, 2003; 17(5): 845 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Dobson, C. P. F. Redfern, N. Unwin, and J. U. Weaver The N363S Polymorphism of the Glucocorticoid Receptor: Potential Contribution to Central Obesity in Men and Lack of Association with Other Risk Factors for Coronary Heart Disease and Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2270 - 2274. [Abstract] [Full Text]
|
|
|
|
|
|
A. White, D. W. Ray, A. Talbot, P. Abraham, A. J. Thody, and J. S. Bevan Cushing's Syndrome Due to Phaeochromocytoma Secreting the Precursors of Adrenocorticotropin J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4771 - 4775. [Abstract] [Full Text]
|
|
|
|
|
|
D. W. Ray, C.-S. Suen, A. Brass, J. Soden, and A. White Structure/Function of the Human Glucocorticoid Receptor: Tyrosine 735 Is Important for Transactivation Mol. Endocrinol., November 1, 1999; 13(11): 1855 - 1863. [Abstract] [Full Text]
|
|
|
|
|
|
P. D. Reynolds, Y. Ruan, D. F. Smith, and J. G. Scammell Glucocorticoid Resistance in the Squirrel Monkey Is Associated with Overexpression of the Immunophilin FKBP51 J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 663 - 669. [Abstract] [Full Text]
|
|
|
|
|
|
P. L. M. Dahia, J. Honegger, M. Reincke, R. A. Jacobs, A. Mirtella, R. Fahlbusch, G. M. Besser, S. L. Chew, and A. B. Grossman Expression of Glucocorticoid Receptor Gene Isoforms in Corticotropin-Secreting Tumors J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1088 - 1093. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
